, a U.K.-based health technology startup that uses machine learning and big data analyses to help predict and manage chronic diseases in patients, has raised $25 million in a series B round of funding led by Leaps by Bayer, the VC arm of German pharmaceutical giant , with participation from NWS Holdings, Healthbox, among other investors.

Founded out of London in 2011, Medopad connects patients with a range of medical professionals with a view to “understand, treat, and ultimately prevent ill health,” as the company puts it. At the heart of its platform is that integrates health data from medical bodies as well as from mobile devices and wearables worn by patients, and through applying AI to the large datasets it said that it can

Read More At Article Source | Article Attribution